| Literature DB >> 35722076 |
Girija S Sajjan1, Gnana Sindhu Dutta1, K Madhu Varma1, R Kalyan Satish1, Anil Kumar Pulidindi1, Vishal Babu Kolla1.
Abstract
Introduction: Bulk-fill composite restorations displayed substantial annual failure related to imperfect marginal adaptation. Although preheated composites improved, marginal adaptation demonstrated early loss of plasticity. A new technique of ultrasonics plasticization was used for fabricating restorations. Aim: The aim of this study was to assess the clinical behavior of bulk-fill composite resin restorations plasticized by preheating and ultrasonics. Methodology: Randomized split-mouth double-blinded clinical trial was designed. Bulk-fill composite resin (Tetric N-Ceram Bulk Fill Ivoclar Vivadent products, Delhi) was used to fill 56 cavities. In 28 restorations, composite resin was plasticized by preheating in composite warmer (Delta Co., India) and remaining were plasticized with modified ultrasonic-retreatment tip-RT No 2 (Cricdental, India). Clinical follow-up assessments were done at 6 and 12 months using Ryge's criteria. Mann-Whitney U-test was used for statistical analysis with P < 0.05 and effect size of 0.61.Entities:
Keywords: Clinical trial; Ryge's criteria; composite resins; surface properties
Year: 2022 PMID: 35722076 PMCID: PMC9200177 DOI: 10.4103/jcd.jcd_333_21
Source DB: PubMed Journal: J Conserv Dent ISSN: 0972-0707
Figure 1CONSORT flowchart showing flow of participants along the study
Mann-Whitney U-test software used: SPSS version 23.0
| USPHS criteria | Code | 6 months | 12 months | ||||
|---|---|---|---|---|---|---|---|
|
|
| ||||||
| Prewarmed, | Ultrasonic, |
| Prewarmed, | Ultrasonic, |
| ||
| Color match | Alpha | 21 (100.0) | 21 (100.0) | 1.000 | 21 (100.0) | 21 (100.0) | 1.000 |
| Bravo | - | - | - | - | |||
| Charlie | - | - | - | - | |||
| Marginal adaptation | Alpha | 20 (95.2) | 21 (100.0) | 0.317 | 20 (95.2) | 21 (100.0) | 0.317 |
| Bravo | - | - | - | - | |||
| Charlie | 1 (4.8) | 0 | 1 (4.8) | 0 | |||
| Surface roughness | Alpha | 21 (100.0) | 21 (100.0) | 1.000 | 19 (90.5) | 21 (100.0) | 0.152 |
| Bravo | - | - | 2 (9.5) | - | |||
| Charlie | - | - | - | - | |||
| Anatomic form | Alpha | 20 (95.2) | 21 (100.0) | 0.317 | 20 (95.2) | 21 (100.0) | 0.317 |
| Bravo | - | - | - | - | |||
| Charlie | 1 (4.8) | 0 | 1 (4.8) | 0 | |||
| Retention | Alpha | 20 (95.2) | 21 (100.0) | 0.317 | 20 (95.2) | 21 (100.0) | 0.317 |
| Bravo | - | - | - | - | |||
| Charlie | 1 (4.8) | 0 | 1 (4.8) | 0 | |||
| Postoperative sensitivity | Alpha | 20 (95.2) | 21 (100.0) | 0.317 | 20 (95.2) | 21 (100.0) | 0.317 |
| Bravo | - | - | |||||
| Charlie | 1 (4.8) | 0 | 1 (4.8) | 0 | |||
| Secondary caries | Alpha | 21 (100.0) | 21 (100.0) | 1.000 | 21 (100.0) | 21 (100.0) | 1.000 |
| Bravo | - | - | - | - | |||
| Charlie | - | - | - | - | |||
USPHS: United States Public Health Service